Skip to main content

Table 3 The estimated average treatment effect of ABC based regimen on opportunistic infections at JMC

From: Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort study

Treatment group

Coefficient (β)

AI Robust Standard Errors

p

95% CI

AZT

Base Regimen

ABC

ATE

0.0112

0.0566

0.844

−0.0998, 0.1221

ATET

0.0217

0.0750

0.772

−0.1253, 0.1688